SkyQuest Technology Group recently introduced Gene Panel Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Gene Panel Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Gene Panel Market size was valued at USD 2.86 Billion in 2023 and is poised to grow from USD 3.41 Billion in 2024 to USD 14.02 Billion by 2032, growing at a CAGR of 19.30% during the forecast period (2025-2032).
The quick development of personalized medicine and genetic technologies. Gene panels are now more reasonably priced due to the decline in the cost of genomic sequencing, which makes comprehensive genetic testing and analysis of a broad variety of illnesses possible. The rising incidence of hereditary diseases and the expanding demand for precise, customized treatment plans are driving this expansion. Additionally, as gene panels offer helpful insights into genetic predispositions and potential treatment options, their growing application in research, diagnostics, and therapeutic development is propelling market expansion.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/gene-panel-market
The 2025 global Gene Panel Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Gene Panel Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Gene Panel Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region.
Based on Product and Services, the market is segmented into Test Kits, and Testing Services.
Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach.
Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel.
Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics.
Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Gene Panel Market – Regional Analysis:
North America dominates the global gene panel market due to its advanced healthcare infrastructure, high investment in biotechnology research, and a strong focus on personalized medicine. Through the allocation of massive funds for genomic research within this region, one can observe that there are strong regulatory structures already in place as well as a high uptake of advanced technologies.
Europe is the fastest-growing region in the global gene panel market due to increasing investments in genomic research and advancements in healthcare technologies. A powerful government assistance and finances made available for scientific inquiry have made this region a gainer considering developments in individualized pharmacotherapy and accurate medical treatment.
Top Market Players in Gene Panel Market are:
Qiagen
Roche
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
Becton, Dickinson and Company (BD)
Sangamo Therapeutics
Genomics England
Personalis, Inc.
Twist Bioscience Corporation
Castle Biosciences, Inc
Neogenomics Laboratories
NantHealth
Macrogen
Myrtelle Inc.
Eurofins Genomics
Guardant Health, Inc.
Myriad Genetic Laboratories Inc.
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/gene-panel-market
Recent Developments:
In August 2024, in a bid to revolutionize gene panel sequencing through greater accuracy and affordability, Illumina introduced the NovaSeq X series, a groundbreaking platform. The latest technology seeks to fast track both research and clinical usage by increasing throughput and improving sensitivity levels; thus, affirming Illumina’s dominance in genomics.
In July 2024, Thermo Fisher Scientific introduced the Oncomine Precision Assay, a comprehensive gene panel for oncology research. This new panel offers expanded coverage of cancer-related genes, enabling more detailed genomic profiling and supporting the development of targeted cancer therapies, thereby advancing precision medicine.
In June 2024, Qiagen unveiled the QIAseq Immune Repertoire Panel, designed to enhance immune system gene analysis. The purpose of this panel is analyzing immune-related genes in detail that helps to investigate the various types of immune disorders, while also positioning Qiagen as a leading company in the field of immunogenomics through personalized immunotherapy methods.
Take Action Now: Secure Your Gene Panel Market Today – https://www.skyquestt.com/buy-now/gene-panel-market
Forward-Looking Insights
The Gene Panel Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]




